Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Long-Term Deferred Tax (2021 - 2023)

Historic Long-Term Deferred Tax for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to -$8.6 million.

  • ADC Therapeutics' Long-Term Deferred Tax fell 1447.68% to -$8.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$8.6 million, marking a year-over-year decrease of 1447.68%. This contributed to the annual value of $37.1 million for FY2022, which is 14233924.91% up from last year.
  • Per ADC Therapeutics' latest filing, its Long-Term Deferred Tax stood at -$8.6 million for Q3 2023, which was down 1447.68% from -$8.1 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Long-Term Deferred Tax registered a high of $37.1 million during Q4 2022, and its lowest value of -$8.6 million during Q3 2023.
  • In the last 3 years, ADC Therapeutics' Long-Term Deferred Tax had a median value of -$1.9 million in 2021 and averaged $8.8 million.
  • As far as peak fluctuations go, ADC Therapeutics' Long-Term Deferred Tax soared by 14233924.91% in 2022, and later plummeted by 12369.27% in 2023.
  • Over the past 3 years, ADC Therapeutics' Long-Term Deferred Tax (Quarter) stood at $26049.0 in 2021, then soared by 142339.25% to $37.1 million in 2022, then plummeted by 123.29% to -$8.6 million in 2023.
  • Its Long-Term Deferred Tax was -$8.6 million in Q3 2023, compared to -$8.1 million in Q2 2023 and $27.6 million in Q1 2023.